Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Updates Surg] 2023 Oct; Vol. 75 (7), pp. 1997-2004. <i>Date of Electronic Publication: </i>2023 May 24.
- MeSH Terms: Breast Neoplasms* ; Carcinoma* ; Humans ; Female ; Prognosis ; Retrospective Studies ; Internet
- References: Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17–48. https://doi.org/10.3322/caac.21763. (PMID: 10.3322/caac.2176336633525) ; Fu L, Ikuo M, Fu XY, Liu TH, Shinichi T (2004) Relationship between biologic behavior and morphologic features of invasive micropapillary carcinoma of the breast. Zhonghua Bing Li Xue Za Zhi 33(1):21–25. (PMID: 14989923) ; Luna-More S, Gonzalez B, Acedo C, Rodrigo I, Luna C (1994) Invasive micropapillary carcinoma of the breast. A new special type of invasive mammary carcinoma. Pathol Res Pract 190(7):668–674. https://doi.org/10.1016/S0344-0338(11)80745-4. ; Siriaunkgul S, Tavassoli FA (1993) Invasive micropapillary carcinoma of the breast. Mod Pathol 6(6):660–662. (PMID: 8302807) ; Luna-More S, de los Santos F, Breton JJ, Canadas MA (1996) Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas. Pathol Res Pract 192(1):27–32. https://doi.org/10.1016/S0344-0338(96)80126-9. ; Middleton LP, Tressera F, Sobel ME et al (1999) Infiltrating micropapillary carcinoma of the breast. Mod Pathol 12(5):499–504. (PMID: 10349988) ; Paterakos M, Watkin WG, Edgerton SM, Moore DH 2nd, Thor AD (1999) Invasive micropapillary carcinoma of the breast: a prognostic study. Hum Pathol 30(12):1459–1463. https://doi.org/10.1016/s0046-8177(99)90168-5. (PMID: 10.1016/s0046-8177(99)90168-510667424) ; Li W, Han Y, Wang C et al (2018) Precise pathologic diagnosis and individualized treatment improve the outcomes of invasive micropapillary carcinoma of the breast: a 12-year prospective clinical study. Mod Pathol 31(6):956–964. https://doi.org/10.1038/s41379-018-0024-8. (PMID: 10.1038/s41379-018-0024-829403084) ; Meng X, Ma H, Yin H et al (2021) Nomogram predicting the risk of locoregional recurrence after mastectomy for invasive micropapillary carcinoma of the breast. Clin Breast Cancer 21(4):e368–e376. https://doi.org/10.1016/j.clbc.2020.12.003. (PMID: 10.1016/j.clbc.2020.12.00333414079) ; Yu JI, Choi DH, Huh SJ et al (2015) Differences in prognostic factors and failure patterns between invasive micropapillary carcinoma and carcinoma with micropapillary component versus invasive ductal carcinoma of the breast: retrospective multicenter case–control study (KROG 13-06). Clin Breast Cancer 15(5):353–361 e1–2. https://doi.org/10.1016/j.clbc.2015.01.008. ; Balachandran VP, Gonen M, Smith JJ, DeMatteo RP (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16(4):e173–e180. https://doi.org/10.1016/S1470-2045(14)71116-7. (PMID: 10.1016/S1470-2045(14)71116-7258460974465353) ; Zhou YJ, Ye FZ, Li YY et al (2019) Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram. Unit Eur Gastroenterol J 7(8):1124–1134. https://doi.org/10.1177/2050640619868352. (PMID: 10.1177/2050640619868352) ; Doll KM, Rademaker A, Sosa JA (2018) Practical guide to surgical data sets: surveillance, epidemiology, and end results (SEER) database. JAMA Surg 153(6):588–589. https://doi.org/10.1001/jamasurg.2018.0501. (PMID: 10.1001/jamasurg.2018.050129617544) ; Pettinato G, Manivel CJ, Panico L, Sparano L, Petrella G (2004) Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior. Am J Clin Pathol 121(6):857–866. https://doi.org/10.1309/XTJ7-VHB4-9UD7-8X60. (PMID: 10.1309/XTJ7-VHB4-9UD7-8X6015198358) ; Walsh MM, Bleiweiss IJ (2001) Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol 32(6):583–589. https://doi.org/10.1053/hupa.2001.24988. (PMID: 10.1053/hupa.2001.2498811431712) ; Chen L, Fan Y, Lang RG et al (2008) Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases. Int J Surg Pathol 16(2):155–163. https://doi.org/10.1177/1066896907307047. (PMID: 10.1177/106689690730704718417672) ; Yang YL, Liu BB, Zhang X, Fu L (2016) Invasive micropapillary carcinoma of the breast: an update. Arch Pathol Lab Med 140(8):799–805. https://doi.org/10.5858/arpa.2016-0040-RA. (PMID: 10.5858/arpa.2016-0040-RA27472238) ; Lewis GD, Xing Y, Haque W et al (2019) Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the National Cancer Database. Cancer Commun (Lond) 39(1):60. https://doi.org/10.1186/s40880-019-0406-4. (PMID: 10.1186/s40880-019-0406-431639071) ; Aker FV, Ekren E, Dogan M et al (2022) Clinicopathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma-NOS: Worse or better? J Coll Physicians Surg Pak 32(9):1196–1201. https://doi.org/10.29271/jcpsp.2022.09.1196. (PMID: 10.29271/jcpsp.2022.09.119636089720) ; Jiang C, Xiu Y, Qiao K et al (2022) Prediction of lymph node metastasis in patients with breast invasive micropapillary carcinoma based on machine learning and SHapley Additive exPlanations framework. Front Oncol 12:981059. https://doi.org/10.3389/fonc.2022.981059. ; Nassar H, Wallis T, Andea A et al (2001) Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol 14(9):836–841. https://doi.org/10.1038/modpathol.3880399. (PMID: 10.1038/modpathol.388039911557778) ; De la Cruz C, Moriya T, Endoh M et al (2004) Invasive micropapillary carcinoma of the breast: clinicopathological and immunohistochemical study. Pathol Int 54(2):90–96. https://doi.org/10.1111/j.1440-1827.2004.01590.x. (PMID: 10.1111/j.1440-1827.2004.01590.x14720138) ; Zhao Y, Li S, Yan L et al (2022) Nomogram for predicting overall survival in patients with invasive micropapillary carcinoma after breast-conserving surgery: a population-based analysis. Front Surg 9:1009149. https://doi.org/10.3389/fsurg.2022.1009149. (PMID: 10.3389/fsurg.2022.1009149363386309634413) ; Wu SG, Zhang WW, Sun JY et al (2017) Postoperative radiotherapy for invasive micropapillary carcinoma of the breast: an analysis of surveillance, epidemiology, and end results database. Cancer Manag Res 9:453–459. https://doi.org/10.2147/CMAR.S141338. (PMID: 10.2147/CMAR.S141338290568545635851) ; Osborne CK, Fisher E, Redmond C et al (1981) Estrogen receptor, a marker for human breast cancer differentiation and patient prognosis. Adv Exp Med Biol 138:377–385. https://doi.org/10.1007/978-1-4615-7192-6_23. (PMID: 10.1007/978-1-4615-7192-6_237342719) ; Clark GM, Osborne CK, McGuire WL (1984) Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol 2(10):1102–1109. https://doi.org/10.1200/JCO.1984.2.10.1102. (PMID: 10.1200/JCO.1984.2.10.11026491696) ; Yu JI, Choi DH, Park W et al (2010) Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study. Breast 19(3):231–237. https://doi.org/10.1016/j.breast.2010.01.020. (PMID: 10.1016/j.breast.2010.01.02020304650) ; Luna-More S, Casquero S, Perez-Mellado A et al (2000) Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 54. Pathol Res Pract 196(1):35–39. https://doi.org/10.1016/S0344-0338(00)80019-9. ; Wu Y, Zhang N, Yang Q (2017) The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis. BMC Cancer 17(1):839. https://doi.org/10.1186/s12885-017-3855-7. (PMID: 10.1186/s12885-017-3855-7292289105725780) ; Overgaard M, Hansen PS, Overgaard J et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337(14):949–955. https://doi.org/10.1056/NEJM199710023371401. ; Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241. https://doi.org/10.1056/NEJMoa022152. (PMID: 10.1056/NEJMoa02215212393820) ; Li D, Zhong C, Cheng Y et al (2019) A competing nomogram to predict survival outcomes in invasive micropapillary breast cancer. J Cancer 10(27):6801–6812. https://doi.org/10.7150/jca.27955. (PMID: 10.7150/jca.27955318398146909950) ; Chen AC, Paulino AC, Schwartz MR et al (2014) Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast. Br J Cancer 111(3):619–622. https://doi.org/10.1038/bjc.2014.301. (PMID: 10.1038/bjc.2014.301249219214119976)
- Grant Information: spy202114 double training project of the First Affiliated Hospital of Wenzhou Medical University; Y20220867 Science and Technology Plan Project of Wenzhou, China; 202110343009 National College Students Innovation and Entrepreneurship Training Program
- Contributed Indexing: Keywords: HR immunochemistry status; Invasive micropapillary carcinoma; Prognosis; Web-based novel model
- Entry Date(s): Date Created: 20230524 Date Completed: 20231002 Latest Revision: 20231002
- Update Code: 20231215
|